Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Cancer Causes & Control
Published in: Cancer Causes & Control 5/1998

01-10-1998

The role of prostate-specific antigen (PSA) testing patterns in the recent prostate cancer incidence declinein the United States

Authors: Julie M. Legler, Eric J. Feuer, Arnold L. Potosky, Ray M. Merrill, Barnett S. Kramer

Published in: Cancer Causes & Control | Issue 5/1998

Login to get access
Metadata
Title
The role of prostate-specific antigen (PSA) testing patterns in the recent prostate cancer incidence declinein the United States
Authors
Julie M. Legler
Eric J. Feuer
Arnold L. Potosky
Ray M. Merrill
Barnett S. Kramer
Publication date
01-10-1998
Publisher
Kluwer Academic Publishers
Published in
Cancer Causes & Control / Issue 5/1998
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1023/A:1008805718310

Other articles of this Issue 5/1998

Cancer Causes & Control 5/1998 Go to the issue

OriginalPaper

Evaluating local differences in breast cancer incidence rates: A census-based methodology (United States)

OriginalPaper

Dietary factors and the risk of squamous cell esophageal cancer among black and white men in the United States

OriginalPaper

Maternal health and pre- and perinatal characteristics in the etiology of testicular cancer: a prospective population- and register-based study on Norwegian males born between 1967 and 1995

OriginalPaper

An extended study on childhood malignancies in the vicinity of German nuclear power plants

OriginalPaper

Physical activity and cancer etiology: associations and mechanisms

OriginalPaper

National Cancer Institute Division of Cancer Epidemiology and Genetics Bethesda, Maryland
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits